Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb
Product Sizes
100 µg
£768.00
12-2003-100UG
About this Product
- SKU:
- 12-2003
- Clonality:
- Monoclonal
- Extra Details:
- Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody; a member of the interleukin inhibitors that selectively block interleukin-23 p19. It usually is important in the treatment of Psoriasis. IL-23 is an inflammatory cytokine responsible for the induction of psoriatic plaque formation. It activates the CD4+ T-helper (Th17) cell pathway. Guselkumab biosimilar developed by Abeomics is for research use only and should not be used in diagnostic procedures.
- Isotype:
- IgG1
- Purification:
- Purified from cell culture supernatant by affinity chromatography
- Reactivities:
- Human
- Shipping Conditions:
- Blue Ice
- Storage Conditions:
- Store at -20[o]C to -80[o]C (Avoid repeated freezing and thawing).
- Supplier:
- Abeomics
- Type:
- Antibodies:Monoclonal Antibody
- Manufacturer's Data Sheet:12-2003 Tremfya Coomassie 031423.jpg
